The monitoring of minimal residual disease (MRD) through low sensitivity real-time (RT)
polymerase chain reaction (PCR) analysis of BCR-ABL transcripts allows early detection of …

We identified 243 patients with Philadelphia (Ph) chromosome–positive chronic myeloid
leukemia (CML) who had BCR-ABL transcripts monitored by quantitative reverse …

The reverse transcriptase–polymerase chain reaction (RT-PCR) has become widely used
for monitoring minimal residual disease after allogeneic stem cell transplantation (SCT) for …

The reverse transcriptase‐polymerase chain reaction (RT‐PCR) was compared with
fluorescence in situ hybridization (FISH) and real‐time quantitative RT‐PCR (RQ‐PCR) for …

Chronic myeloid leukemia (CML) relapse after allogeneic stem cell transplantation (SCT) is
a relatively frequent situation, which is correlated to disease status, time from diagnosis to …

We have developed a competitive polymerase chain reaction (PCR) titration assay that
estimates the number of BCR-ABL transcripts in chronic myeloid leukemia patients to …

Relapse of chronic myelogenous leukemia after bone marrow transplantation can be
detected by using clinical, cytogenetic, or molecular tools. A modification of the polymerase …

Serial assays of qualitative (multiplex and nested) and quantitative PCR were carried out for
detecting and estimating the level of BCR-ABL transcripts in 39 CML patients following bone …

We performed a two-step polymerase chain reaction (PCR) to detect bcr-abl-specific mRNA
in 440 peripheral blood and/or bone marrow samples of 30 chronic myeloid leukemia (CML) …

To test whether patients in remission after allogeneic bone marrow transplantation (BMT)
possess a pool of chronic myeloid leukemia (CML) cells that do not express BCR-ABL …